Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

DSpace Repository

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Author: Dal Pra, A.; Ghadjar, P.; Ryu, H. M.; Proudfoot, J. A.; Hayoz, S.; Michalski, J. M.; Spratt, D. E.; Liu, Y.; Schaer, C.; Berlin, A. M.; Zwahlen, D. R.; Simko, J. P.; Hoelscher, T.; Efstathiou, J. A.; Polat, B.; Sandler, H. M.; Hildebrandt, G.; Parliament, M. B.; Mueller, A. -C.; Dayes, I. S.; Plasswilm, L.; Correa, R. J. M.; Robertson, J. M.; Karrison, T. G.; Davicioni, E.; Hall, W. A.; Feng, F. Y.; Pollack, A.; Thalmann, G. N.; Nguyen, P. L.; Aebersold, D. M.; Tran, P. T.; Zhao, S. G.
Tübinger Autor(en):
Müller, Arndt-Christian
Published in: Annals of Oncology (2025), Bd. 36, H. 5, S. 572-582
Verlagsangabe: Amsterdam : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.annonc.2025.01.017
ISSN: 0923-7534
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)